The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Martin B. Leon

Columbia University Medical Center

Center for Interventional Vascular Therapy

173 Fort Washington Avenue

Heart Center

USA

[email]@crf.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Columbia University Medical Center, Center for Interventional Vascular Therapy, 173 Fort Washington Avenue, Heart Center, USA. 2011
  • Columbia University Medical Center, New York, New York 10032, USA. 2006 - 2011
  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA. 2009 - 2010
  • Cardiovascular Research Foundation, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, USA. 2005 - 2009
  • Cardiovascular Research Foundation, Lenox Hill Hospital, New York, NY 10021, USA. 2001

References

  1. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Leon, M.B., Piazza, N., Nikolsky, E., Blackstone, E.H., Cutlip, D.E., Kappetein, A.P., Krucoff, M.W., Mack, M., Mehran, R., Miller, C., Morel, M.A., Petersen, J., Popma, J.J., Takkenberg, J.J., Vahanian, A., van Es, G.A., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W. Eur. Heart J. (2011) [Pubmed]
  2. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Leon, M.B., Piazza, N., Nikolsky, E., Blackstone, E.H., Cutlip, D.E., Kappetein, A.P., Krucoff, M.W., Mack, M., Mehran, R., Miller, C., Morel, M.A., Petersen, J., Popma, J.J., Takkenberg, J.J., Vahanian, A., van Es, G.A., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W. J. Am. Coll. Cardiol. (2011) [Pubmed]
  3. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. Leon, M.B., Nikolsky, E., Cutlip, D.E., Mauri, L., Liberman, H., Wilson, H., Patterson, J., Moses, J., Kandzari, D.E. JACC. Cardiovasc. Interv (2010) [Pubmed]
  4. A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. Leon, M.B., Mauri, L., Popma, J.J., Cutlip, D.E., Nikolsky, E., O'Shaughnessy, C., Overlie, P.A., McLaurin, B.T., Solomon, S.L., Douglas, J.S., Ball, M.W., Caputo, R.P., Jain, A., Tolleson, T.R., Reen, B.M., Kirtane, A.J., Fitzgerald, P.J., Thompson, K., Kandzari, D.E. J. Am. Coll. Cardiol. (2010) [Pubmed]
  5. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Leon, M.B., Kandzari, D.E., Eisenstein, E.L., Anstrom, K.J., Mauri, L., Cutlip, D.E., Nikolsky, E., O'Shaughnessy, C., Overlie, P.A., Kirtane, A.J., McLaurin, B.T., Solomon, S.L., Douglas, J.S., Popma, J.J. JACC. Cardiovasc. Interv (2009) [Pubmed]
  6. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. Leon, M.B., Allocco, D.J., Dawkins, K.D., Baim, D.S. JACC. Cardiovasc. Interv (2009) [Pubmed]
  7. Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Leon, M.B., Kodali, S., Williams, M., Oz, M., Smith, C., Stewart, A., Schwartz, A., Collins, M., Moses, J.W. Semin. Thorac. Cardiovasc. Surg. (2006) [Pubmed]
  8. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. Leon, M.B., Kornowski, R., Downey, W.E., Weisz, G., Baim, D.S., Bonow, R.O., Hendel, R.C., Cohen, D.J., Gervino, E., Laham, R., Lembo, N.J., Moses, J.W., Kuntz, R.E. J. Am. Coll. Cardiol. (2005) [Pubmed]
  9. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. Leon, M.B., Teirstein, P.S., Moses, J.W., Tripuraneni, P., Lansky, A.J., Jani, S., Wong, S.C., Fish, D., Ellis, S., Holmes, D.R., Kerieakes, D., Kuntz, R.E. N. Engl. J. Med. (2001) [Pubmed]
 
WikiGenes - Universities